The UC Lung Cancer Consortium (UCLCC) puts cutting-edge research, translational medicine and clinical practice from UC’s five NCI-designated Comprehensive Cancer Centers to bear on prevention, personalized treatment and care for all Californians, especially the state’s most vulnerable populations.

Clinical trials and projects

Lung cancer clinical trials across the UC system

Current trials

Upcoming events

Lung Cancer Consortium Quarterly Young Investigators and Journal Club
January 9, 2024 5:30pm PT
Speakers: Elisa Tong, M.D., M.A. and Britany Lundberg, M.D., UC Davis
Title: Tobacco History Population Data Issues and American Cancer Society's Lung Cancer Screening Guidelines
Registration and additional details available here.

For more information about upcoming meetings, contact Pauline McAlpin.

Funding opportunities

The UC Lung Cancer Consortium supports projects that encourage collaboration among UC campuses. For additional information, contact Pauline McAlpin.

Awards

2022

Novel Multi-Omics Ultra-short ctDNA for Early Detection of NSCLC: David Wong, M.D. (UCLA)

2021

​Targeting TIGIT in Malignant Pleural Mesothelioma: Tianhong Li, M.D. (UC Davis)

About us

Our vision is to foster systemwide collaboration to drive transformation of lung cancer prevention, therapeutic advances and care—including disparities in access to precision treatment.

Leadership

UC Davis Comprehensive Cancer Center
Megan Daly, M.D.
Tianhong “Tina” Li, M.D.

UC Irvine Chao Family Comprehensive Cancer Center
Jeremy Harris, M.D.
Hari Keshava, M.D.

UCLA Jonsson Comprehensive Cancer Center
Amy Cummings, M.D.
Jonathan Goldman, M.D. (Chair)

UC San Diego Moores Cancer Center
Mark Onaitis, M.D.
Sandip Patel, M.D.

UCSF Helen Diller Family Comprehensive Cancer Center
Jason Chan, M.D.
Michael Cheng, M.D. (Co-Chair)

Working groups

  • Diagnostics ​
  • Novel Therapeutics
  • Population Health and Policy
  • Screening and Prevention Taskforce
  • Tumor Biology